Gold tier: mechanically validated evidence, with its primary source.
2,235 evidence items · page 39 / 90
76 %Among children who were unsuppressed at baseline, three-month multimonth dispensing (3MMD) was associated with a 76% higher likelihood of viral suppression (adjusted risk ratio 1.76, 95% CI: 1.30–2.37).
KenyaVIH/sidapublished 2024Journal of acquired immune deficiency syndromes (1999)PubMeddocument of 8 observations
0.23 per_100_person-yearsHIV incidence was 0.23 per 100 person-years postpartum.
KenyaVIH/sidapublished 2022Global health, science and practicePubMeddocument of 3 observations
11 %La fréquence de la neuropathie chez les personnes vivant avec le VIH au Kenya était de 11 % en 2011.
KenyaVIH/sidaobserved 2011HAL · Unilimdocument of 747 observations
6 %Between May 1, 2018, and March 31, 2020, 1910 out of 32,722 female individuals tested positive for HIV in western Kenya, representing a prevalence of 6% among those receiving HIV testing services.
KenyaVIH/sidaobserved May 1, 2018 to March 31, 2020published 2023The Lancet. Global healthPubMeddocument of 11 observations
4.52 odds_ratioAdjusted odds of viral failure were higher for guidelines-unsupported versus supported regimens (OR = 4.52; 95% CI 1.02–26.24).
KenyaVIH/sidapublished 2025Journal of the International AIDS SocietyPubMeddocument of 15 observations
71 %Among 358 partner participants who knew they were HIV positive, 358 (71%) were virally suppressed.
KenyaVIH/sidapublished 2024The Lancet. Global healthPubMeddocument of 7 observations
2.11 timesAfter adjusting for age and individual-level risk factors, HIV prevalence was 2.11 times higher among nonvenue adolescent girls and young women not engaged in sex work compared with venue-based adolescent girls and young women not engaged in sex work in Mombasa, Kenya.
KenyaVIH/sidapublished 2024Journal of acquired immune deficiency syndromes (1999)PubMeddocument of 6 observations
46 %Among 437 pregnant women living with HIV in western Kenya, 46% disclosed their HIV status to a relative.
KenyaVIH/sidapublished 2020BMC pregnancy and childbirthPubMeddocument of 11 observations
74 %Among 54 children with 560 viral load visits followed from 48 to 96 months, five viral load trajectory groups were identified: sustained-low (74%), mid-range (4%), periods-of-low (7%), high-to-low (7%), and sustained-high (7%).
KenyaVIH/sidapublished 2024Journal of acquired immune deficiency syndromes (1999)PubMeddocument of 5 observations
1.9 timesOver 3 years, the risk of HIV acquisition was 1.9 times higher in those living ≥ 1 month outside their community in the past 12 months compared to those who had not.
KenyaVIH/sidapublished 2025AIDS and behavioreurope_pmcdocument of 18 observations
99 %Among 1743 female partners of male partners (FPPs) reporting a prior HIV diagnosis, 99% were on antiretroviral treatment (ART) at baseline.
KenyaVIH/sidaobserved 2018 to 2022published 2024Journal of the International AIDS SocietyPubMeddocument of 10 observations
7.69 odds_ratioHIV-1 seropositive women were nearly 8 times as likely to have genital warts compared with HIV-1-seronegative women, with an odds ratio of 7.69.
Kenyagenital warts · VIH/sidaobserved 2001-2007published 2012Sexually transmitted diseaseseurope_pmcdocument of 3 observationsDOI 10.1097/olq.0b013e318275ec7f
123 casesHIV genotyping was successful for 123 out of 124 prevalent cases and all 21 seroconverters.
KenyaVIH/sidapublished 2021Clinical infectious diseases : an official publication of the Infectious Diseases Society PubMeddocument of 6 observations
300 IC(50)Elite neutralizer activity is defined as the ability to neutralize, on average, more than one pseudovirus at an IC(50) titer of 300 within a clade group and across at least four clade groups.
KenyaVIH/sidapublished 2009Journal of virologyeurope_pmcdocument of 2 observationsDOI 10.1128/jvi.00110-09
4.8 %In the BREATHER Plus trial, the estimated probability of confirmed HIV-1 RNA ≥50 copies per mL by week 96 was 4.8% in the continuous ART group.
KenyaVIH/sidapublished 2026The lancet. HIVPubMeddocument of 10 observations
0.92 aRRInternalized HIV stigma was independently associated with lower likelihood of successful completion of PMTCT (adjusted risk ratio 0.92; 95% confidence interval 0.88–0.98).
KenyaVIH/sidaobserved 2017published 2021International journal of gynaecology and obstetrics: the official organ of the InternationPubMeddocument of 4 observations
9.7 %Among 3152 participants who inject drugs in Kenya, 306 (9.7%) were HIV-positive.
KenyaVIH/sidapublished 2025The International journal on drug policyPubMeddocument of 6 observations
37,900,000 inhabitantsGlobally, people infected with HIV/AIDS were estimated to be 37.9 million in 2018.
KenyaVIH/sidaobserved 2018published 2020African Journal of Health SciencesOpenAlexdocument of 7 observations
5 %At week 48, 5.0% of participants in the dolutegravir group met the primary end point of plasma HIV type 1 RNA level of at least 50 copies per milliliter.
KenyaVIH/sidaobserved week 48published 2023The New England journal of medicinePubMeddocument of 8 observations
25 %Among 1,384 young adults living with HIV in Western Kenya, the prevalence of lifetime violence was 25% in male patients under 20 years.
KenyaVIH/sidapublished 2026The Journal of the Association of Nurses in AIDS Care : JANACPubMeddocument of 8 observations
4.9 %HIV prevalence rate in Kenya was 4.9% among the general population aged 15–64 years.
KenyaVIH/sidapublished 2020African Journal of Health SciencesOpenAlexdocument of 7 observations
68 %68% of women agreed that their male partner would want to receive text messages during PMTCT care.
KenyaVIH/sidapublished 2021AIDS carePubMeddocument of 7 observations
1,813 individualsAmong children and adolescents living with HIV in central Kenya, 1,813 (37.7%) were enrolled at WHO stage II disease.
KenyaVIH/sidapublished 2022AIDS research and human retrovirusesPubMeddocument of 18 observations
89 %Point-of-care viral load testing uptake was high (>89%) throughout pregnancy, delivery, and postpartum periods.
KenyaVIH/sidapublished 2023Journal of the International AIDS SocietyPubMeddocument of 8 observations
52 %More than half (52%) of mortality among HIV-positive tuberculosis patients was ascribed to advanced HIV disease.
Kenyatuberculose · VIH/sidapublished 2023African health sciencesPubMeddocument of 6 observations
Every row leads to its source document. The figure shown counts the VALIDATED observations it carries, never the extracted ones: the two differ on most documents. The exact source excerpt is not published, due to copyright constraints.